已发表论文

HPV 整合检测有助于避免 Ia1 期宫颈癌患者的误诊:一病例报告和文献综述

 

Authors Li J, Zhang X, Wang P, Li W

Received 22 July 2021

Accepted for publication 26 October 2021

Published 18 November 2021 Volume 2021:14 Pages 1457—1461

DOI https://doi.org/10.2147/PGPM.S310345

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Martin H Bluth

Abstract: Screening and prevention in the early stage of cervical cancer could improve the 5-year survival rate of cervical cancer by up to 90%. The occurrence rate of human papillomavirus (HPV) integration has gradually increased with the development of cervical lesions. Here, we report the case of a 43-year-old woman diagnosed with chronic cervicitis based on cervical biopsy results. After medical consultation, surgery was recommended to the patient considering her 64 HPV integration sites and other biochemical and clinical test results. The pathology result of the conical biopsy obtained during operation confirmed that both her cervix and the glands had high-grade squamous intraepithelial lesion or cervical intraepithelial neoplasia III (HSIL/CIN III). The patient underwent uterectomy and bilateral salpingectomy and was discharged thereafter. The diagnosis of the patient was revised to stage Ia1 cervical cancer. The number of HPV integration sites is suggested to be an auxiliary indicator in the early screening of cervical cancer for predicting high-grade CIN and invasive cervical cancer.
Keywords: HPV DNA, DNA methylation detection, cervical cancer, precancerous lesion of cervical cancer